Sphera Global Healthcare Fund

Sphera Global Healthcare Fund is a long/short equity fund that is focused on the global pharmaceutical and biotech industries.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Sphera Global Healthcare Fund Information

Geographic Data

Sphera Global Healthcare Fund headquarters map

Address: 9th Floor

City: New York

State: NY

Zip: 10017

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Sphera Global Healthcare Management (Investment Manager) is a partnership between Mr. Mori Arkin, former vice chairman of Perrigo (Nasdaq ticker:PRGO, a world leader in generic and OTC drugs), and of Sphera Funds Management. It is a long/short equity fund that is focused on the global pharmaceutical and biotech industries. The Investment Manager’s objective is to generate consistent and attractive long term returns exceeding the industry while maintaining disciplined risk management. With a highly experienced and cohesive multidisciplinary team, the Fund’s competitive advantage is evident in three key areas: • Having a rigorous, fundamental, focused and comprehensive approach to healthcare research. • Investment committee co- led by an industry veteran with a track record of building a pharmaceutical company. • Unique and unbiased investment approach generated in part from access to massive flow of R &a;D, innovation and top tier human capital in Israel.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
10/2022 Immunic Therapeutics Post-IPO Equity 60M
9/2021 BioAtla Post-IPO Equity 0
6/2017 Deciphera Pharmaceuticals Series C 52M
3/2021 Immune-Onc Therapeutics Series B 0
7/2021 Frontier Medicines Series B 0
1/2021 Werewolf Therapeutics Series B 0
8/2020 ESSA Pharma Post-IPO Equity 0
10/2020 LianBio Series A 0
7/2019 Frontier Medicines Series B 88.5M
12/2020 Yumanity Therapeutics Venture Round 0
7/2021 Point Biopharma Post-IPO Equity 0
9/2020 I-Mab Biopharma Post-IPO Equity 0
7/2020 Cerevel Therapeutics Post-IPO Equity 0
11/2015 ObsEva Series B 60M
3/2015 aTyr Pharma Series E 76M
8/2020 Chinook Therapeutics Private Placement 106M
8/2018 Orchard Therapeutics Series C 0
9/2021 BioAtla Post-IPO Equity 0
7/2021 Frontier Medicines Series B 0
7/2021 Point Biopharma Post-IPO Equity 0
3/2021 Immune-Onc Therapeutics Series B 0
1/2021 Werewolf Therapeutics Series B 0
12/2020 Yumanity Therapeutics Venture Round 0
10/2020 LianBio Series A 0
9/2020 I-Mab Biopharma Post-IPO Equity 0
8/2020 Chinook Therapeutics Post-IPO Equity 0
8/2020 ESSA Pharma Post-IPO Equity 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research